Protein SORLA Protects Brain From Alzheimer's Damage

Scientists have identified a protein named SORLA that may offer significant protection against the tau tangles characteristic of Alzheimer's disease. In studies involving mice, those genetically engineered to have higher levels of SORLA exhibited reduced tau accumulation, less brain atrophy, and maintained healthier neuronal connections compared to control groups. Conversely, mice lacking SORLA displayed more pronounced damage associated with the disease.

The research, published in the journal Cell, suggests that SORLA plays a crucial role in preventing the buildup of toxic tau proteins, which are a hallmark of Alzheimer's pathology. The protein appears to regulate the transport of specific molecules within brain cells, thereby preventing the misfolding and aggregation of tau.

Furthermore, the study's findings point to a potential therapeutic avenue. The researchers discovered that SORLA's activity is linked to the behavior of microglia, the brain's immune cells. By modulating SORLA's function, it may be possible to control the harmful inflammatory responses of these supporting brain cells, which can exacerbate neurodegeneration in Alzheimer's disease. This opens the door for developing new drug targets aimed at enhancing SORLA's protective effects or mitigating the detrimental actions of microglia.